Business Wire

Test of LED System that Warns Drivers of Black Ice Under Way in Susono, Japan

2.3.2023 15:32:00 EET | Business Wire | Press release

Share

Susono City, Stanley Electric Co., Ltd., Kaga FEI Co., Ltd., NTT Communications Corporation and Dassault Systèmes K.K.. announced jointly today that a system for warning drivers about transparent ("black") ice using a smart streetlight developed by the four companies is being tested on a public road in Susono, Japan from February 10 to March 31. The test will verify the effectiveness of the system in preventing car slippage and pedestrian falls in a public area of Susono.

For the test, a smart streetlight that projects an illuminated warning ("Caution Ice") on the road surface was installed on a light pole in front of Yanagibata Bridge in Ishiwaki, Susono City. During the test, data from an edge AI camera and sensors mounted on the smart streetlight are being collected and transmitted via mobile communication to a center for analysis, including by comparing the number of ice-related accidents at the site before and after the test. Also, residents will be surveyed to see if their awareness of ice-related hazards is changed by the operation of the system.

The roles of each company are as follow:

Stanley Electric:

  • Develop, manufacture and supply LED streetlight and illumination-projection equipment  

Kaga FEI:

  • Provide edge AI camera and sensors
  • Develop embedded AI system

NTT Communications:

  • Implement mobile communications (IoT Connect Mobile® TypeS1)
  • Provide platform for visualizing and storing collected data (Things Cloud®2)

Dassault Systèmes:

  • Provide virtual twin3 platform (3DEXPERIENCE© platform)
  • Build virtual twins, data visualization, and scenario analysis based on system and terrain data

Once the system is demonstrated to be fully reliable and effective, its broad deployment in other municipalities will be promoted along with the use of smart streetlights in emerging countries where road lighting is uncommon. In addition, by combining data from the system with weather data, etc., it will be possible to provide enhanced weather-related driving information, such as traffic congestion forecasts in areas where snow is expected, keeping drivers better informed while also supporting the work of road and traffic managers.

NTT Com's KOEL4 design studio will join the project to help research opportunities for commercial applications. It is expected that the system could be applied in business areas such as shopping malls and other commercial facilities as well as Park-PFI, a publicly solicited, privately financed initiative for the maintenance and management of urban parks in Japan.

Susono, which has adopted the slogan "Japan's most citizen-oriented city hall," is actively modernizing its urban areas through the introduction of universal-design pedestrian spaces, advanced technology and data analysis, aiming to realize zero fatalities and less than 200 injuries due to accidents per year by 2025.

1 IoT Connect Mobile® TypeS is an eSIM-based mobile data communication service.
2 Things Cloud® is an IoT platform that packages data collection, visualization, analysis and management functions via connected sensors and devices tailored to specific business environments.
3 Virtual twin, more than a digital copy of the real world, is a representation of the real world based on mathematical models and scientific principles.
4 The KOEL design studio was established in April 2020 within NTT Com's Innovation Center, which is dedicated to the creation of new businesses.

About Stanley Electric

Stanley Electric Co., Ltd. was founded in 1920 to manufacture and sell automotive light bulbs and other specialty light bulbs. Today, the company is highly regarded worldwide for products it supplies to major automobile manufacturers. Starting with the world's first commercial high-brightness LEDs in 1976, the company has developed numerous components and other electronic that contribute to safety and energy conservation, including smart streetlights. Please visit https://www.stanley.co.jp/

About Kaga FEI

Kaga FEI Co., Ltd. is an electronics trading company that sells consumer and industrial electronic devices and products for automobiles, AV equipment, communications equipment and information processing equipment. The company and its global partners also provide technical support and solution services that combine commercial products and technologies, including electronics manufacturing services, in markets worldwide. Please visit https://www.kagafei.com/jp/

About NTT Communications

NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 500,000m2 of the world's most advanced data-center facilities. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating 'virtual twin experiences’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production.
Dassault Systèmes’ 20,000 employees are bringing value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit https://www.3ds.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information
Susono
Business: Strategic Promotion Division
+81-55-995-1804; kikaku@city.susono.shizuoka.jp
Road management: Construction Management Division
+81-55-995-1855; kanri@city.susono.shizuoka.jp

Stanley Electric
Yokohama Technical Center, Lighting Application Division
+81-45-910-6629

Kaga FEI
Partner Business Promotion Department
System Business Center, Solutions Division
ml-snk_colbiz_pj@jp.kagafei.com

NTT Communications
Business Solution Division, Business Solution Department
bbx-5bs3g@ntt.com

Dassault Systèmes
Marketing Representative, Public Relations Division
+81-3-4321-3506; japan.marketing@3ds.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye